However, antagonism of VEGF by its endogenous inhibitor (soluble VEGFR-1/sFlt-1) in preeclampsia and monoclonal antibody against VEGF in cancer patients causes proteinuria and renal dysfunction [44]. Here, VEGFA is linked to cancer.